The endoplasmic reticulum (ER) aminopeptidases ERAP1 and ERAP2 are two multifunctional enzymes playing an important role in the biological processes requiring trimming of substrates, including the generation of major histocompatibility complex (MHC) class I binding peptides. In the absence of ERAP enzymes, the cells exhibit a different pool of peptides on their surface which can promote both NK and CD8+ T cell-mediated immune responses. The expression of ERAP1 and ERAP2 is frequently altered in tumors, as compared to their normal counterparts, but how this affects tumor growth and anti-tumor immune responses has been little investigated. This review will provide an overview of current knowledge on transcriptional and post-transcriptional regulations of ERAP enzymes, and will discuss the contribution of recent studies to our understanding of ERAP1 and ERAP2 role in cancer immunity.

Compagnone, M., Cifaldi, L.c., Fruci, D. (2019). Regulation of {ERAP}1 and {ERAP}2 genes and their disfunction in human cancer. HUMAN IMMUNOLOGY, 80(5), 318-324 [10.1016/j.humimm.2019.02.014].

Regulation of {ERAP}1 and {ERAP}2 genes and their disfunction in human cancer

Loredana Cifaldi
Membro del Collaboration Group
;
2019-02-01

Abstract

The endoplasmic reticulum (ER) aminopeptidases ERAP1 and ERAP2 are two multifunctional enzymes playing an important role in the biological processes requiring trimming of substrates, including the generation of major histocompatibility complex (MHC) class I binding peptides. In the absence of ERAP enzymes, the cells exhibit a different pool of peptides on their surface which can promote both NK and CD8+ T cell-mediated immune responses. The expression of ERAP1 and ERAP2 is frequently altered in tumors, as compared to their normal counterparts, but how this affects tumor growth and anti-tumor immune responses has been little investigated. This review will provide an overview of current knowledge on transcriptional and post-transcriptional regulations of ERAP enzymes, and will discuss the contribution of recent studies to our understanding of ERAP1 and ERAP2 role in cancer immunity.
feb-2019
Pubblicato
Rilevanza internazionale
Recensione
Esperti anonimi
Settore MED/04 - PATOLOGIA GENERALE
English
Con Impact Factor ISI
Aminopeptidase
Antigen processing
Cancer
Genetic alterations
Transcription factors
Aminopeptidases
Animals
Antigen Presentation
Endoplasmic Reticulum
Genetic Variation
Genomics
Histocompatibility Antigens Class I
Humans
Immunotherapy
Minor Histocompatibility Antigens
Neoplasms
Protein Binding
Transcription, Genetic
Gene Expression Regulation, Neoplastic
Compagnone, M., Cifaldi, L.c., Fruci, D. (2019). Regulation of {ERAP}1 and {ERAP}2 genes and their disfunction in human cancer. HUMAN IMMUNOLOGY, 80(5), 318-324 [10.1016/j.humimm.2019.02.014].
Compagnone, M; Cifaldi, Lc; Fruci, D
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/263967
Citazioni
  • ???jsp.display-item.citation.pmc??? 24
  • Scopus 42
  • ???jsp.display-item.citation.isi??? 39
social impact